MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization

Autor:	Bielack, S.S., Smeland, S., Whelan, J., Marina, N., Hook, J., Jovic, G., Krailo, M.D., Butterfass-Bahloul, T., Kuhne, T., Eriksson, M., Teot, L.A., Gelderblom, H., Kager, L., Hall, K.S., Gorlick, R.G., Randall, R.L., Hogendoorn, P.C.W., Calaminus, G., Sydes, M.R., Bernstein, M.L.
Jazyk:	angličtina
Rok vydání:	2013
Zdroj:	Journal of Clinical Oncology, 31(15)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cd979c50b2596c31f389a4040cfb4a91 http://hdl.handle.net/1887/105374 Zobrazit plný text záznamu